Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEHYY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,167
Award facts
- Contract value 100% obligated
- $17,167.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,167.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 7, 2025, with an ultimate completion date of November 20, 2025, was issued without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is performing under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract, a $30.3 billion government-wide acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
Under the PPV-G GEN V contract vehicle, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceuticals including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to support recurring medical supply needs of military healthcare operations. The contractor's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals. The underlying indefinite delivery contract, awarded November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, provides a 30-month base period with three 30-month option periods, positioning DMS Pharmaceutical Group as a critical supplier within the federal military pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEHYY?
SPE2DU26FEHYY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DU26FEHYY worth?
The government has obligated $17,167 on SPE2DU26FEHYY.
Is contract SPE2DU26FEHYY an order under another contract?
Yes. SPE2DU26FEHYY is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHYY competed?
The extent of competition for SPE2DU26FEHYY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award